Publicaciones en colaboración con investigadores/as de Universidad de Extremadura (26)

2012

  1. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma

    Oncology, Vol. 82, Núm. 1, pp. 35-40

  2. Predicting response to therapy in chronic hepatitis C: An approach combining interleukin-28B gene polymorphisms and clinical data

    Journal of Gastroenterology and Hepatology (Australia), Vol. 27, Núm. 2, pp. 279-285

  3. Relation of IL28b gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease

    PLoS ONE, Vol. 7, Núm. 5

2009

  1. Analysis of a non-synonymous single nucleotide polymorphism of the human diamine oxidase gene (ref. SNP ID: Rs1049793) in patients with Crohn's disease

    Scandinavian Journal of Gastroenterology, Vol. 44, Núm. 10, pp. 1207-1212

2008

  1. Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding

    Pharmacogenetics and Genomics, Vol. 18, Núm. 1, pp. 37-43

2007

  1. GSTT1 and GSTM1 null genotypes may facilitate hepatitis C virus infection becoming chronic

    Journal of Infectious Diseases, Vol. 195, Núm. 9, pp. 1320-1323

  2. Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients

    BMC Cancer, Vol. 7

  3. Glutathione S-transferases π1, α1 and μ3 genetic polymorphisms and the risk of hepatocellular carcinoma in humans

    Pharmacogenomics, Vol. 8, Núm. 8, pp. 895-899

2006

  1. Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: A study in the Spanish population

    European Journal of Cancer, Vol. 42, Núm. 1, pp. 73-77

  2. Glutathione S-transferases μ1, θ1, π1 α1 and μ3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans

    Pharmacogenomics, Vol. 7, Núm. 5, pp. 711-718

  3. Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene

    World Journal of Gastroenterology, Vol. 12, Núm. 4, pp. 615-620

2005

  1. Polymorhisms in the transforming growth factor-β1 gene (TGF-β1) and the risk of advanced alcoholic liver disease

    Liver International, Vol. 25, Núm. 5, pp. 935-939

  2. Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease

    Scandinavian Journal of Gastroenterology, Vol. 40, Núm. 3, pp. 348-353

2004

  1. Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use

    British Journal of Pharmacology, Vol. 141, Núm. 2, pp. 205-208

  2. Leflunomide-induced acute hepatitis

    Digestive and Liver Disease, Vol. 36, Núm. 1, pp. 82-84

2002

  1. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma

    Cancer Chemotherapy and Pharmacology, Supplement, Vol. 49, Núm. 7, pp. 115-118

  2. Single nucleotide polymorphisms and microsatellite alleles of tumor necrosis factor alpha and interleukin-10 genes and the risk of advanced chronic alcoholic liver disease

    Liver, Vol. 22, Núm. 3, pp. 245-251

2001

  1. Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk

    Carcinogenesis, Vol. 22, Núm. 8, pp. 1323-1326

1997

  1. CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis

    Pharmacogenetics, Vol. 7, Núm. 3, pp. 247-250

1996

  1. Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers

    Pharmacogenetics, Vol. 6, Núm. 6, pp. 501-512